Nursing Diagnosis of Respiratory System: Acute Respiratory Distress Syndrome (ARDS)

Introduction

Acute Respiratory Distress Syndrome (ARDS) stands as a critical, life-threatening condition encountered in severely ill patients, significantly impairing oxygenation and manifesting as pulmonary infiltrates with an abrupt onset. At the cellular level, ARDS is characterized by damage to the capillary endothelium and widespread alveolar injury.

ARDS is clinically defined as an acute condition marked by bilateral lung infiltrates and severe, progressive hypoxemia, crucially occurring without evidence of cardiogenic pulmonary edema. The severity of ARDS is assessed by the ratio of partial pressure of oxygen in arterial blood (PaO2) to the fraction of inspired oxygen (FiO2). Patients with ARDS typically present with a PaO2/FiO2 ratio below 300 mmHg, often falling under 200 mmHg in more severe cases.

Upon the development of ARDS, patients frequently experience varying degrees of pulmonary artery vasoconstriction, potentially leading to pulmonary hypertension. ARDS is associated with a high mortality rate, underscoring the urgency for effective therapeutic interventions and robust nursing care strategies. The role of nursing in managing patients with ARDS is paramount, focusing on respiratory support, monitoring, and preventing complications. Understanding the Nursing Diagnosis Of Respiratory System in ARDS is crucial for effective patient care and improved outcomes.

Nursing Diagnoses for ARDS

Nursing diagnoses are essential in guiding the care plan for patients with ARDS. Based on the pathophysiology and clinical presentation of ARDS, several key nursing diagnoses are pertinent:

• Impaired Gas Exchange: Related to alveolar-capillary membrane changes, including increased permeability, pulmonary edema, and decreased lung compliance. This is a primary nursing diagnosis in ARDS, directly addressing the core physiological problem of oxygenation and carbon dioxide removal.
• Ineffective Breathing Pattern: Associated with alveolar collapse, pain, anxiety, and ventilator dependency. Patients may exhibit tachypnea, dyspnea, and the use of accessory muscles.
• Ineffective Airway Clearance: Due to increased production of secretions, decreased ability to cough effectively, and potential presence of artificial airway.
• Activity Intolerance: Resulting from hypoxemia, dyspnea, and fatigue. Patients with ARDS often experience profound weakness and reduced functional capacity.
• Risk for Aspiration: Related to decreased level of consciousness, presence of feeding tubes, and impaired cough reflex, especially in ventilated patients.
• Anxiety: (Specify level: mild, moderate, severe, panic) Related to dyspnea, fear of death, unfamiliar environment of the intensive care unit (ICU), and dependence on medical interventions.

These nursing diagnoses provide a framework for nurses to assess patient needs, plan interventions, and evaluate outcomes in the context of ARDS. Each diagnosis directs specific nursing actions aimed at optimizing respiratory function and overall patient well-being.

Causes of ARDS

ARDS is not a primary disease but a syndrome triggered by various direct and indirect insults to the lungs. The diverse etiology of ARDS underscores the complexity of its pathogenesis and the challenges in its management.

Common causes of ARDS include:

• Pulmonary Infections: Pneumonia, particularly severe bacterial or viral pneumonia, is a leading cause of ARDS. Pathogens directly damage the lung parenchyma, initiating the inflammatory cascade.
• Aspiration: Aspiration of gastric contents, especially in patients with impaired consciousness or swallowing difficulties, can cause severe lung injury and ARDS.
• Sepsis: Systemic infection and sepsis are major extra-pulmonary causes of ARDS. Inflammatory mediators released during sepsis can travel to the lungs, causing diffuse alveolar damage.
• Trauma: Severe trauma, especially chest trauma, multiple fractures, or traumatic brain injury, can lead to ARDS. Trauma-induced inflammation and shock contribute to lung injury.
• Massive Transfusion: Transfusion-related acute lung injury (TRALI) is a rare but serious cause of ARDS, triggered by antibodies in transfused blood products reacting with recipient leukocytes.
• Drowning: Near-drowning incidents, particularly in freshwater, can wash away surfactant and cause direct lung damage, leading to ARDS.
• Drug Overdose: Overdose of certain drugs, such as opioids or salicylates, can induce ARDS through various mechanisms including direct toxicity or aspiration.
• Fat Embolism: Fat embolism syndrome, often associated with long bone fractures, can result in fat globules lodging in pulmonary capillaries, causing inflammation and ARDS.
• Inhalation of Toxic Fumes: Inhalation of smoke, toxic gases, or irritants can directly injure the airways and alveoli, precipitating ARDS.
• Pancreatitis: Severe acute pancreatitis is an extra-pulmonary condition that can trigger systemic inflammation and lead to ARDS.

These diverse causes converge on a common pathway of pulmonary inflammation and injury, ultimately resulting in the clinical syndrome of ARDS. Recognizing the underlying cause is essential for guiding treatment strategies and addressing the root of the respiratory distress.

Figure: Pathophysiology of Acute Respiratory Distress Syndrome. Image illustrates the key pathological changes in ARDS, including alveolar damage, inflammation, and edema, leading to impaired gas exchange.

Risk Factors for ARDS

Identifying risk factors for ARDS is crucial for early recognition and potentially preventive strategies in at-risk populations. While ARDS can affect individuals of any age, certain factors increase susceptibility:

• Advanced Age: Older adults are at higher risk of developing ARDS, possibly due to age-related decline in physiological reserves and immune function.
• Female Gender: Some studies suggest a slightly increased risk of ARDS in females, although the reasons are not fully understood and may relate to hormonal or inflammatory responses.
• Smoking: History of smoking is associated with increased risk and severity of ARDS. Smoking damages the lungs and impairs defense mechanisms, making individuals more vulnerable to lung injury.
• Alcohol Use: Chronic alcohol abuse is also linked to a higher risk of ARDS, potentially due to its impact on immune function and increased susceptibility to infections.
• Pre-existing Lung Conditions: Individuals with pre-existing lung diseases, such as chronic obstructive pulmonary disease (COPD) or asthma, may have a reduced threshold for developing ARDS when exposed to triggers.
• Immunocompromised Status: Patients with weakened immune systems, such as those with HIV/AIDS, transplant recipients, or those on immunosuppressive medications, are at increased risk of infections that can lead to ARDS.
• Genetic Predisposition: Emerging research suggests that genetic factors may play a role in ARDS susceptibility and severity, with variations in genes involved in inflammation and lung injury response.

Understanding these risk factors allows healthcare professionals to be vigilant in monitoring high-risk patients, implementing preventive measures where possible, and ensuring prompt diagnosis and management if ARDS develops.

Assessment of ARDS

The clinical assessment of a patient with suspected ARDS is critical for timely diagnosis and intervention. ARDS typically presents with a constellation of signs and symptoms that reflect the underlying pulmonary dysfunction.

Key assessment findings include:

• History: Obtain a detailed history focusing on potential causes or risk factors, such as recent infections, aspiration events, trauma, or exposure to toxins. Document the onset and progression of symptoms. Patients who are able to communicate may initially complain of dyspnea, which rapidly escalates within 12 to 24 hours.
• Respiratory Symptoms:
  • Dyspnea: Shortness of breath is a hallmark symptom, progressing from mild to severe.
  • Tachypnea: Increased respiratory rate is common as the body attempts to compensate for hypoxemia.
  • Increased Work of Breathing: Patients may exhibit signs of increased respiratory effort, including use of accessory muscles (neck and intercostal muscles), nasal flaring, and retractions.
• Physical Examination:
  • Auscultation: Lung sounds may reveal rales (crackles), particularly bibasilar, but can be heard throughout the chest as edema and infiltrates become widespread.
  • Cyanosis: Central or peripheral cyanosis may be present due to hypoxemia.
  • Tachycardia: Increased heart rate is a compensatory response to hypoxemia and stress.
  • Altered Mental Status: Hypoxemia can affect brain function, leading to restlessness, confusion, and decreased level of consciousness.
• Oxygen Saturation: Despite supplemental oxygen, patients with ARDS typically exhibit persistently low oxygen saturation (SpO2) levels. Even with 100% FiO2, adequate oxygenation may not be achievable without mechanical ventilation.

A comprehensive assessment, integrating history, respiratory symptoms, physical findings, and oxygenation status, is crucial for recognizing ARDS and differentiating it from other causes of respiratory distress. Prompt and accurate assessment guides the subsequent diagnostic evaluation and initiation of appropriate management strategies.

Evaluation and Diagnostic Tests for ARDS

The diagnosis of ARDS is based on specific clinical and radiographic criteria, along with ruling out other conditions such as cardiogenic pulmonary edema. Evaluation involves a combination of clinical assessment, imaging, and laboratory tests.

Diagnostic criteria for ARDS include:

• Acute Onset: Respiratory symptoms must have an acute onset, typically within hours to days of the inciting event.
• Bilateral Lung Infiltrates: Chest radiography or CT scan shows bilateral opacities (infiltrates) that are not fully explained by effusions, lobar or lung collapse, or nodules. The infiltrates must be of non-cardiac origin.
• Hypoxemia: Defined by the PaO2/FiO2 ratio.
  • Mild ARDS: PaO2/FiO2 ratio 200 to 300 mmHg with positive end-expiratory pressure (PEEP) or continuous positive airway pressure (CPAP) ≥ 5 cm H2O.
  • Moderate ARDS: PaO2/FiO2 ratio 100 to 200 mmHg with PEEP ≥ 5 cm H2O.
  • Severe ARDS: PaO2/FiO2 ratio < 100 mmHg with PEEP ≥ 5 cm H2O.
• Exclusion of Cardiogenic Pulmonary Edema: Heart failure as the primary cause of respiratory failure must be ruled out. If heart failure is present, ARDS is still diagnosed if the respiratory failure is not fully explained by cardiac failure or fluid overload.

Additional diagnostic tests may include:

• Chest Radiography: Initial imaging modality to identify bilateral infiltrates.
• CT Scan of the Chest: May be indicated for unclear cases, to evaluate for pneumothorax, pleural effusions, mediastinal lymphadenopathy, or barotrauma. CT scan can provide more detailed information about the distribution and nature of lung infiltrates.
• Arterial Blood Gas (ABG) Analysis: To assess oxygenation (PaO2), carbon dioxide levels (PaCO2), and acid-base balance. PaO2/FiO2 ratio is calculated from ABG results.
• Assessment of Left Ventricular Function: To rule out or quantify the contribution of heart failure. This can be done non-invasively with echocardiography, or in some cases, invasively with a pulmonary artery catheter (although the latter is less common due to associated risks and limited benefit in ARDS management).
• Bronchoscopy: May be performed to obtain bronchoalveolar lavage fluid for culture and to rule out or diagnose pulmonary infections.
• Laboratory Tests: Complete blood count (CBC), comprehensive metabolic panel, coagulation studies, inflammatory markers (e.g., C-reactive protein, procalcitonin), and markers of organ dysfunction (e.g., lactate, liver function tests, renal function tests) are often obtained to assess overall clinical status and identify underlying causes or complications.

The diagnostic evaluation aims to confirm ARDS, determine its severity, identify potential underlying causes, and exclude other conditions that mimic ARDS. This comprehensive approach ensures appropriate and targeted management strategies are implemented.

Figure: Chest Radiograph of Neonatal Respiratory Distress Syndrome. This X-ray demonstrates diffuse ground-glass haziness bilaterally with air bronchograms, characteristic of respiratory distress syndrome, showing the typical radiographic findings in ARDS.

Medical Management of ARDS

The medical management of ARDS is primarily supportive, as there is no specific pharmacological treatment to reverse the underlying lung injury. The focus is on maintaining organ function, optimizing oxygenation, and preventing complications while the lungs heal.

Key strategies in medical management include:

• Mechanical Ventilation: Often necessary to support oxygenation and ventilation. Lung-protective ventilation strategies are crucial to minimize ventilator-induced lung injury (VILI).
  • Low Tidal Volume Ventilation: Using tidal volumes of 4-8 mL/kg of ideal body weight (IBW) to prevent volutrauma.
  • Limiting Plateau Pressure: Maintaining plateau pressure < 30 cm H2O to reduce barotrauma.
  • Positive End-Expiratory Pressure (PEEP): Applying PEEP to prevent alveolar collapse (atelectrauma) and improve oxygenation. ARDSnet protocols guide PEEP settings based on FiO2.
• Fluid Management: Judicious fluid management is essential. While adequate hydration is necessary, conservative fluid strategy to avoid fluid overload is generally preferred to minimize pulmonary edema and improve oxygenation. Diuretics may be used to manage fluid balance.
• Prone Positioning: Placing patients in the prone position (lying on their stomach) has been shown to improve oxygenation in a significant proportion of ARDS patients (50-70%). Prone positioning promotes more uniform alveolar ventilation and perfusion. It is typically implemented for at least 8 hours a day.
• Neuromuscular Blockade: In severe ARDS, neuromuscular blocking agents may be used for short periods (e.g., first 48 hours) to improve ventilator synchrony, reduce oxygen consumption, and potentially improve survival.
• Pharmacological Therapies:
  • No Proven Disease-Modifying Drugs: Currently, no drugs are definitively proven to directly treat ARDS. Corticosteroids were initially considered but are not routinely recommended and may be harmful in some ARDS etiologies.
  • Antibiotics: Used if bacterial infection is identified as the underlying cause or if secondary infections develop.
  • Experimental Therapies: Research continues to explore potential therapies, including surfactant replacement, inhaled nitric oxide, and stem cell therapy, but these are not yet standard of care.
• Extracorporeal Membrane Oxygenation (ECMO): In cases of severe refractory hypoxemia despite optimized mechanical ventilation and prone positioning, ECMO may be considered as a salvage therapy. ECMO provides external respiratory support, allowing the lungs to rest and recover.
• Nutritional Support: Early enteral nutrition is recommended to maintain nutritional status and support healing. A diet high in fat and low in carbohydrates, enriched with gamma-linolenic acid and eicosapentaenoic acid, has been suggested in some studies to potentially improve oxygenation.
• Supportive Care: Comprehensive supportive care is crucial, including:
  • Deep Vein Thrombosis (DVT) Prophylaxis: To prevent thromboembolic complications.
  • Stress Ulcer Prophylaxis: To reduce the risk of gastrointestinal bleeding.
  • Pressure Ulcer Prevention: Frequent repositioning and skin care to prevent pressure sores.
  • Physical Therapy: Early mobilization and physical therapy once the patient is stable to prevent muscle weakness and improve functional recovery.

Medical management of ARDS is complex and requires a multidisciplinary approach. The primary goal is to support the patient through the acute phase of lung injury, allowing time for lung repair and recovery, while minimizing complications and optimizing long-term outcomes.

Nursing Management in ARDS

Nursing care is integral to the management of patients with ARDS, encompassing respiratory support, monitoring, prevention of complications, and psychological support.

Key nursing interventions include:

• Respiratory Management:
  • Mechanical Ventilation Management: Nurses play a critical role in managing patients on mechanical ventilation. This includes:
    • Monitoring ventilator settings: Ensuring adherence to prescribed parameters (tidal volume, respiratory rate, PEEP, FiO2).
    • Assessing respiratory status: Monitoring respiratory rate, rhythm, depth, breath sounds, and work of breathing.
    • Monitoring oxygenation and ventilation: Continuously monitoring SpO2 and ABGs, and reporting changes promptly.
    • Managing artificial airway: Ensuring proper endotracheal tube or tracheostomy tube placement and securing, providing oral care, and preventing tube displacement.
    • Suctioning: Performing airway suctioning as needed to maintain airway clearance, being careful to minimize airway trauma and hypoxemia.
  • Positioning: Implementing prone positioning as ordered and managing patient safety during prone therapy, including securing lines and tubes and monitoring for complications. Regular turning and repositioning in supine and lateral positions to promote lung expansion and prevent atelectasis.
  • Oxygen Therapy: Administering supplemental oxygen as prescribed, monitoring response, and adjusting FiO2 as indicated by oxygen saturation and ABG levels.
• Hemodynamic Monitoring:
  • Vital Signs Monitoring: Continuous monitoring of heart rate, blood pressure, and temperature.
  • Fluid Balance Management: Strict monitoring of fluid intake and output, daily weights, and assessment for signs of fluid overload or dehydration. Administering diuretics as prescribed and monitoring their effectiveness.
• Medication Administration:
  • Administering prescribed medications: Ensuring timely and accurate administration of antibiotics, sedatives, analgesics, neuromuscular blocking agents, DVT prophylaxis, stress ulcer prophylaxis, and other medications.
  • Monitoring for medication side effects and interactions.
• Nutritional Support:
  • Enteral Nutrition: Initiating and managing enteral feeding as prescribed, monitoring tolerance, and preventing complications such as aspiration.
  • Monitoring nutritional status: Assessing for signs of malnutrition and collaborating with dietitians to optimize nutritional support.
• Infection Prevention:
  • Ventilator-Associated Pneumonia (VAP) Prevention: Implementing VAP prevention bundles, including head-of-bed elevation, oral care, subglottic suctioning, and minimizing ventilator circuit breaks.
  • Central Line-Associated Bloodstream Infection (CLABSI) Prevention: Adhering to central line insertion and maintenance bundles.
  • Catheter-Associated Urinary Tract Infection (CAUTI) Prevention: Using catheters only when necessary and practicing meticulous catheter care.
• Psychological and Emotional Support:
  • Anxiety Management: Assessing and managing patient anxiety related to dyspnea, ICU environment, and prognosis. Providing reassurance, clear communication, and considering pharmacological and non-pharmacological anxiety management strategies.
  • Family Support: Providing emotional support and education to family members, facilitating communication between the medical team and family, and addressing their concerns.
• Monitoring for Complications:
  • Barotrauma: Observing for signs of pneumothorax or subcutaneous emphysema.
  • Multi-organ Failure: Monitoring for signs of renal, hepatic, cardiovascular, and hematologic dysfunction.
  • Sepsis: Monitoring for signs of secondary infections and sepsis.
• Activity and Mobility:
  • Early Mobilization: Initiating early mobilization and physical therapy as soon as the patient is stable to prevent muscle weakness and improve functional recovery.
  • Range of Motion Exercises: Performing passive and active range of motion exercises to prevent joint stiffness and muscle atrophy.
• Skin Care:
  • Pressure Ulcer Prevention: Implementing pressure ulcer prevention strategies, including frequent repositioning, pressure-relieving devices, and skin assessments.
  • Skin Integrity Monitoring: Regularly assessing skin for breakdown and providing appropriate skin care.

Effective nursing management in ARDS is essential for optimizing patient outcomes, preventing complications, and providing holistic care to patients and their families during this critical illness.

When to Seek Help

Prompt recognition of worsening respiratory status is crucial in patients with ARDS. Healthcare providers should be immediately notified if any of the following signs or symptoms develop or worsen:

• Persistent Hypoxia: Continued low oxygen saturation despite increasing FiO2 or oxygen delivery methods.
• Elevated Peak Airway Pressures: Increasing peak inspiratory pressures or plateau pressures during mechanical ventilation, indicating worsening lung compliance or airway resistance.
• Decreasing Urine Output: Oliguria or anuria, suggesting renal dysfunction and potential multi-organ failure.
• High Fever: Fever unresponsive to antipyretics, potentially indicating infection.
• Unresponsiveness or Altered Mental Status: Significant decline in level of consciousness, indicating worsening hypoxemia or central nervous system dysfunction.
• Hypotension: Low blood pressure despite fluid resuscitation and vasopressor support, suggesting hemodynamic instability.

These signs indicate a deterioration in the patient’s condition and require urgent medical evaluation and intervention. Early recognition and prompt action are essential to optimize outcomes and prevent further complications in ARDS.

Outcome Identification in ARDS

The prognosis for patients with ARDS remains guarded, despite advances in critical care. Even those who survive ARDS often face a prolonged recovery period and may experience long-term sequelae.

Common outcomes in ARDS include:

• Mortality: ARDS carries a significant mortality rate, ranging from 30-50% depending on severity, underlying causes, and patient comorbidities. Mortality increases with ARDS severity (mild, moderate, severe).
• Prolonged Recovery: Survivors often require extended hospitalization and rehabilitation.
• Muscle Wasting and Weakness: Critical illness myopathy and polyneuropathy are common, leading to significant muscle weakness and functional limitations.
• Pulmonary Sequelae: Some patients experience persistent respiratory symptoms, such as dyspnea on exertion, reduced lung function, and chronic respiratory failure.
• Cognitive Impairment: Hypoxia and critical illness can lead to cognitive dysfunction, including memory problems, attention deficits, and executive function impairments.
• Psychological Morbidity: Anxiety, depression, and post-traumatic stress disorder (PTSD) are common in ARDS survivors.
• Reduced Quality of Life: Long-term physical, cognitive, and psychological sequelae can significantly impact patients’ quality of life.

Outcome identification in ARDS involves recognizing both the potential for mortality and the significant morbidity associated with survival. Care planning should address not only acute management but also long-term rehabilitation and support to optimize functional recovery and quality of life for ARDS survivors.

Monitoring in ARDS

Continuous and vigilant monitoring is essential in the management of ARDS patients, typically requiring intensive care unit (ICU) level care.

Key monitoring parameters include:

• Continuous Cardiorespiratory Monitoring:
  • Electrocardiography (ECG): Continuous heart rate and rhythm monitoring.
  • Pulse Oximetry (SpO2): Continuous monitoring of oxygen saturation.
  • Invasive Blood Pressure Monitoring: Arterial line for continuous blood pressure monitoring in hemodynamically unstable patients.
  • Respiratory Rate and Pattern: Continuous monitoring of respiratory rate and pattern of breathing.
• Mechanical Ventilation Monitoring:
  • Ventilator Parameters: Continuous monitoring of tidal volume, respiratory rate, PEEP, FiO2, peak inspiratory pressure, plateau pressure, and minute ventilation.
  • Waveform Capnography: Continuous monitoring of end-tidal carbon dioxide (EtCO2) to assess ventilation.
• Arterial Blood Gas (ABG) Analysis: Regular ABG measurements (arterial partial pressure of oxygen (PaO2), arterial partial pressure of carbon dioxide (PaCO2), pH, bicarbonate) to assess oxygenation, ventilation, and acid-base balance. Frequency depends on patient stability and changes in clinical status.
• Hemodynamic Monitoring:
  • Central Venous Pressure (CVP) Monitoring: May be used to assess fluid status and guide fluid management.
  • Pulmonary Artery Catheter (PAC) Monitoring: Less commonly used, but may be indicated in complex cases to assess cardiac output, pulmonary artery pressures, and pulmonary capillary wedge pressure.
• Urine Output Monitoring: Hourly urine output measurement to assess renal function and fluid balance.
• Laboratory Tests: Regular monitoring of complete blood count (CBC), electrolytes, renal function tests, liver function tests, coagulation studies, and inflammatory markers. Frequency depends on clinical status and organ function.
• Chest Radiography: Daily or as needed chest radiographs to monitor for changes in pulmonary infiltrates, pneumothorax, or pleural effusions.
• Clinical Assessment: Frequent nursing assessments, including respiratory assessment, neurological assessment, skin assessment, and pain assessment.

Comprehensive and continuous monitoring allows for early detection of changes in patient status, prompt intervention, and optimization of therapy in ARDS.

Coordination of Care for ARDS

ARDS is a complex condition requiring a coordinated, interprofessional healthcare team approach to optimize patient outcomes. Effective coordination ensures comprehensive and timely care across various disciplines.

The interprofessional team typically includes:

• Intensivist/Critical Care Physician: Leads the team, manages mechanical ventilation, and oversees overall ICU care, including prevention of complications like pneumonia, DVT, and stress ulcers.
• Pulmonologist: Provides expertise in lung diseases and ARDS management.
• Respiratory Therapist: Manages ventilator settings, airway management, and respiratory treatments.
• Critical Care Nurse: Provides continuous patient monitoring, administers medications, performs nursing interventions, educates the family, and coordinates care.
• Pharmacist: Manages medications, including antibiotics, anticoagulants, diuretics, sedatives, and analgesics, ensuring appropriate dosing and monitoring for drug interactions.
• Dietitian/Nutritionist: Provides nutritional assessment and plans enteral or parenteral nutrition support.
• Nephrologist: Manages renal function and oversees renal replacement therapy if needed.
• Physical Therapist: Implements early mobilization and rehabilitation programs to improve muscle strength and function.
• Occupational Therapist: Addresses functional limitations and helps patients regain independence in activities of daily living.
• Speech Therapist: Evaluates and manages swallowing difficulties, especially in patients with tracheostomy.
• Mental Health Nurse/Psychologist/Psychiatrist: Assesses and manages psychological issues such as anxiety, depression, and PTSD.
• Social Worker: Provides psychosocial support to patients and families, assists with discharge planning, and coordinates resources for rehabilitation and long-term care.
• Chaplain/Spiritual Care Provider: Offers spiritual and emotional support to patients and families.

Effective team communication and collaboration are essential for optimal ARDS management. Regular team meetings, clear communication channels, and shared decision-making ensure a cohesive and integrated approach to patient care.

Outcomes of Interprofessional Care:

Interprofessional team care in ARDS has been shown to improve patient outcomes, including reduced mortality, shorter ICU length of stay, and improved functional recovery. This approach facilitates timely interventions, reduces medical errors, and enhances the overall quality of care for patients with ARDS.

Health Teaching and Health Promotion for ARDS

While ARDS itself is not preventable in many cases, health teaching and health promotion strategies can focus on reducing risk factors and promoting early recognition and treatment of conditions that can lead to ARDS.

Key health teaching and health promotion points:

• Prevention of Aspiration:
  • Elevate head of bed: Keep the head of the bed elevated at least 30-45 degrees during and after meals, especially for patients at risk of aspiration (e.g., those with impaired swallowing or reduced consciousness).
  • Cautious feeding: For patients with swallowing difficulties, ensure proper swallowing evaluation and implement strategies to minimize aspiration risk during feeding.
• Smoking Cessation: Encourage smoking cessation and provide resources for quitting smoking to reduce the risk of lung damage and respiratory illnesses that can predispose to ARDS.
• Moderate Alcohol Consumption: Educate about the risks of excessive alcohol consumption and its potential impact on immune function and susceptibility to infections.
• Vaccination: Promote vaccination against influenza and pneumonia to reduce the risk of severe respiratory infections that can lead to ARDS.
• Early Treatment of Infections: Encourage individuals to seek prompt medical attention for respiratory infections and ensure appropriate and timely treatment to prevent progression to severe pneumonia and ARDS.
• Awareness of Risk Factors: Educate individuals about risk factors for ARDS, especially those with pre-existing conditions or occupational exposures to lung irritants.
• Safe Practices to Avoid Toxic Inhalations: Promote safe practices in workplaces and homes to avoid inhalation of toxic fumes or irritants.

Health teaching and health promotion efforts aim to reduce modifiable risk factors for ARDS and empower individuals to take proactive steps to protect their respiratory health.

Discharge Planning for ARDS Patients

Discharge planning for ARDS survivors is crucial to ensure a smooth transition from hospital to home or rehabilitation settings and to address the long-term needs of patients.

Key components of discharge planning include:

• Medication Reconciliation: Review and reconcile all medications, ensuring patients and caregivers understand medication regimens, dosages, frequency, and potential side effects.
• Home Care Planning: Develop a detailed home care plan, addressing ongoing needs for respiratory support, wound care, nutritional support, mobility assistance, and medication management. Determine if home healthcare services (visiting nurse, physical therapy, etc.) are needed.
• Respiratory Therapy at Home: If patients require ongoing oxygen therapy or respiratory treatments at home, ensure proper equipment, supplies, and education on usage and maintenance.
• Rehabilitation Planning: Arrange for outpatient or home-based physical therapy, occupational therapy, and speech therapy to address muscle weakness, functional limitations, and cognitive or swallowing difficulties.
• Follow-up Appointments: Schedule follow-up appointments with pulmonologist, primary care physician, and other specialists as needed.
• Education and Counseling: Provide comprehensive education to patients and caregivers on ARDS, recovery process, potential long-term sequelae, warning signs of exacerbation, and when to seek medical attention. Offer psychological counseling and support services to address anxiety, depression, or PTSD.
• Community Resources: Connect patients and families with community resources, support groups, and social services to assist with long-term needs and adjustments.
• Emergency Plan: Develop an emergency plan outlining steps to take if respiratory symptoms worsen or other complications arise.

Effective discharge planning is essential to optimize recovery, prevent readmissions, and support ARDS survivors in achieving the best possible quality of life after hospital discharge.

Review Questions

1. What are the major causes of Acute Respiratory Distress Syndrome (ARDS)?
2. Describe the typical clinical presentation of a patient with ARDS.
3. Outline the key principles of medical management for ARDS.
4. Discuss the essential role of nursing in the management of patients with ARDS, focusing on nursing diagnoses and interventions.

---

References

1. Gajic O, Dabbagh O, Park PK, Adesanya A, Chang SY, Hou P, Anderson H, Hoth JJ, Mikkelsen ME, Gentile NT, Gong MN, Talmor D, Bajwa E, Watkins TR, Festic E, Yilmaz M, Iscimen R, Kaufman DA, Esper AM, Sadikot R, Douglas I, Sevransky J, Malinchoc M., U.S. Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators (USCIITG-LIPS). Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med. 2011 Feb 15;183(4):462-70. [PMC free article: PMC3056224] [PubMed: 20802164]
2. Wang Y, Zhang L, Xi X, Zhou JX., China Critical Care Sepsis Trial (CCCST) Workgroup. The Association Between Etiologies and Mortality in Acute Respiratory Distress Syndrome: A Multicenter Observational Cohort Study. Front Med (Lausanne). 2021;8:739596. [PMC free article: PMC8558376] [PubMed: 34733862]
3. Zambon M, Vincent JL. Mortality rates for patients with acute lung injury/ARDS have decreased over time. Chest. 2008 May;133(5):1120-7. [PubMed: 18263687]
4. Shrestha GS, Khanal S, Sharma S, Nepal G. COVID-19: Current Understanding of Pathophysiology. J Nepal Health Res Counc. 2020 Nov 13;18(3):351-359. [PubMed: 33210623]
5. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF, Ranieri M, Rubenfeld G, Thompson BT, Wrigge H, Slutsky AS, Pesenti A., LUNG SAFE Investigators. ESICM Trials Group. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016 Feb 23;315(8):788-800. [PubMed: 26903337]
6. Sedhai YR, Yuan M, Ketcham SW, Co I, Claar DD, McSparron JI, Prescott HC, Sjoding MW. Validating Measures of Disease Severity in Acute Respiratory Distress Syndrome. Ann Am Thorac Soc. 2021 Jul;18(7):1211-1218. [PMC free article: PMC8328371] [PubMed: 33347379]
7. Sharma NS, Lal CV, Li JD, Lou XY, Viera L, Abdallah T, King RW, Sethi J, Kanagarajah P, Restrepo-Jaramillo R, Sales-Conniff A, Wei S, Jackson PL, Blalock JE, Gaggar A, Xu X. The neutrophil chemoattractant peptide proline-glycine-proline is associated with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2018 Nov 01;315(5):L653-L661. [PMC free article: PMC6295514] [PubMed: 30091378]
8. Huang D, Ma H, Xiao Z, Blaivas M, Chen Y, Wen J, Guo W, Liang J, Liao X, Wang Z, Li H, Li J, Chao Y, Wang XT, Wu Y, Qin T, Su K, Wang S, Tan N. Diagnostic value of cardiopulmonary ultrasound in elderly patients with acute respiratory distress syndrome. BMC Pulm Med. 2018 Aug 13;18(1):136. [PMC free article: PMC6090678] [PubMed: 30103730]
9. Vieillard-Baron A, Schmitt JM, Augarde R, Fellahi JL, Prin S, Page B, Beauchet A, Jardin F. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis. Crit Care Med. 2001 Aug;29(8):1551-5. [PubMed: 11505125]
10. Chen WL, Lin WT, Kung SC, Lai CC, Chao CM. The Value of Oxygenation Saturation Index in Predicting the Outcomes of Patients with Acute Respiratory Distress Syndrome. J Clin Med. 2018 Aug 08;7(8) [PMC free article: PMC6111712] [PubMed: 30096809]
11. Rawal G, Yadav S, Kumar R. Acute Respiratory Distress Syndrome: An Update and Review. J Transl Int Med. 2018 Jun;6(2):74-77. [PMC free article: PMC6032183] [PubMed: 29984201]
12. Cherian SV, Kumar A, Akasapu K, Ashton RW, Aparnath M, Malhotra A. Salvage therapies for refractory hypoxemia in ARDS. Respir Med. 2018 Aug;141:150-158. [PMC free article: PMC6186150] [PubMed: 30053961]
13. Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, Clavel M, Chatellier D, Jaber S, Rosselli S, Mancebo J, Sirodot M, Hilbert G, Bengler C, Richecoeur J, Gainnier M, Bayle F, Bourdin G, Leray V, Girard R, Baboi L, Ayzac L., PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013 Jun 06;368(23):2159-68. [PubMed: 23688302]
14. National Heart, Lung, and Blood Institute PETAL Clinical Trials Network. Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA, Gong MN, Grissom CK, Gundel S, Hayden D, Hite RD, Hou PC, Hough CL, Iwashyna TJ, Khan A, Liu KD, Talmor D, Thompson BT, Ulysse CA, Yealy DM, Angus DC. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. N Engl J Med. 2019 May 23;380(21):1997-2008. [PMC free article: PMC6741345] [PubMed: 31112383]
15. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006 Jun 15;354(24):2564-75. [PubMed: 16714767]
16. Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med. 2011 Nov 17;365(20):1905-14. [PubMed: 22087681]
17. Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, Da Silva D, Zafrani L, Tirot P, Veber B, Maury E, Levy B, Cohen Y, Richard C, Kalfon P, Bouadma L, Mehdaoui H, Beduneau G, Lebreton G, Brochard L, Ferguson ND, Fan E, Slutsky AS, Brodie D, Mercat A., EOLIA Trial Group, REVA, and ECMONet. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N Engl J Med. 2018 May 24;378(21):1965-1975. [PubMed: 29791822]
18. Yang P, Formanek P, Scaglione S, Afshar M. Risk factors and outcomes of acute respiratory distress syndrome in critically ill patients with cirrhosis. Hepatol Res. 2019 Mar;49(3):335-343. [PMC free article: PMC6560637] [PubMed: 30084205]
19. Annane D, Pastores SM, Rochwerg B, Arlt W, Balk RA, Beishuizen A, Briegel J, Carcillo J, Christ-Crain M, Cooper MS, Marik PE, Umberto Meduri G, Olsen KM, Rodgers S, Russell JA, Van den Berghe G. Correction to: Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2018 Mar;44(3):401-402. [PubMed: 29476199]
20. Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev. 2016 Mar 07;3:CD010406. [PubMed: 26950335]
21. Anand R, McAuley DF, Blackwood B, Yap C, ONeill B, Connolly B, Borthwick M, Shyamsundar M, Warburton J, Meenen DV, Paulus F, Schultz MJ, Dark P, Bradley JM. Mucoactive agents for acute respiratory failure in the critically ill: a systematic review and meta-analysis. Thorax. 2020 Aug;75(8):623-631. [PMC free article: PMC7402561] [PubMed: 32513777]
22. Gadre SK, Duggal A, Mireles-Cabodevila E, Krishnan S, Wang XF, Zell K, Guzman J. Acute respiratory failure requiring mechanical ventilation in severe chronic obstructive pulmonary disease (COPD). Medicine (Baltimore). 2018 Apr;97(17):e0487. [PMC free article: PMC5944543] [PubMed: 29703009]
23. Chiumello D, Coppola S, Froio S, Gotti M. What’s Next After ARDS: Long-Term Outcomes. Respir Care. 2016 May;61(5):689-99. [PubMed: 27121623]
24. Villar J, Schultz MJ, Kacmarek RM. The LUNG SAFE: a biased presentation of the prevalence of ARDS! Crit Care. 2016 Apr 25;20(1):108. [PMC free article: PMC4843206] [PubMed: 27109238]
25. Bos LD, Cremer OL, Ong DS, Caser EB, Barbas CS, Villar J, Kacmarek RM, Schultz MJ., MARS consortium. External validation confirms the legitimacy of a new clinical classification of ARDS for predicting outcome. Intensive Care Med. 2015 Nov;41(11):2004-5. [PubMed: 26202043]

Disclosures:

Matthew Diamond, Hector Peniston, Devang Sanghavi, Sidharth Mahapatra, and Chaddie Doerr declare no relevant financial relationships with ineligible companies.